STOCK TITAN

Cbd Life Science (CBDL) Stock News

CBDL OTC

Welcome to our dedicated page for Cbd Life Science news (Ticker: CBDL), a resource for investors and traders seeking the latest updates and insights on Cbd Life Science stock.

CBD Life Sciences Inc. develops and distributes CBD, hemp-derived and wellness products through its flagship brand, The CBD Vault. The company's announcements cover product launches across therapeutic topicals, transdermal CBD patches, nicotine-free CBD pouches, edibles, functional mushroom supplements, nutraceutical powders, alkaline CBD functional water, and animal wellness products.

Recurring updates also address retail, wholesale, and online distribution, including specialty retail and dispensary placements, as well as brand expansion under wholly owned subsidiaries Mushroom Madness Inc. and Formrunner Apparel. The company links new formulations and distribution relationships to its broader CBD and functional wellness portfolio.

Rhea-AI Summary

CBD Life Sciences Inc. (OTC PINK:CBDL) has announced a significant partnership between its subsidiary, The CBD Vault Inc, and Sunset Wholesale West, Arizona's largest CBD wholesaler. This collaboration will see The CBD Vault's pain creams, athlete-specific pain relief roll-ons, and gummies distributed through Sunset Wholesale's extensive network.

Sunset Wholesale, established in 2004, operates from a 40,000-square-foot warehouse and carries over 12,000 products. Lisa Nelson, President & CEO of The CBD Vault, expressed enthusiasm about the partnership, highlighting its potential to enhance market penetration and drive substantial revenue growth.

The partnership aligns with The CBD Vault's mission to provide accessible, high-quality CBD products, which are known for their potential benefits in addressing various conditions, including neurological disorders, pain management, and gastrointestinal health issues.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Summary

CBD Life Sciences Inc. (OTC PINK:CBDL) has announced a major distribution milestone for its subsidiary, The CBD Vault Inc. The company's high-strength CBD Pain Relief Cream is now available at the prestigious Red Hots Spa in Roslyn and Garden City, NY. This strategic partnership is expected to enhance brand visibility and accessibility in a key market.

The CBD Pain Relief Cream, containing 3000mg of premium CBD, is designed for muscle, joint, and chronic pain relief. It comes in various scents, including Coconut Mango and Green Tea & Lemongrass. CEO Lisa Nelson projects a 20-30% revenue increase over the next quarter due to this placement, aligning with the company's goals of market expansion and increasing investor value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-55%
Tags
none
-
Rhea-AI Summary

CBD Life Sciences (OTC PINK:CBDL) has launched a new line of Kava & Kratom shots through its subsidiary, The CBD Vault.

These shots are crafted using high-quality natural ingredients for a safe and effective experience.

They come in a sleek, portable bottle, making them convenient for on-the-go use.

The formulation offers a balanced blend of Kava and Kratom for energy and relaxation, available in a delicious apple flavor.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-40%
Tags
none
Rhea-AI Summary

CBD Life Sciences (CBDL) announced the launch of Delta 8 CBD Vape Cartridges. These premium cartridges come in four flavors—Bubba Kush, Watermelon Zkittles, Purple Punch, and Mimosa—offering enhanced therapeutic benefits like stress relief, pain management, and improved sleep quality. The launch is expected to drive a 50% sales increase in the first six months. With the global CBD market projected to reach $13.4 billion by 2028, and vape products being a fast-growing segment, CBDL aims for a strong market position with its full-spectrum, high-quality offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.79%
Tags
none
-
Rhea-AI Summary

CBD Life Sciences (CBDL) announced a strategic initiative to expand its brand, The CBD Vault, into retail stores nationwide, enhancing accessibility and driving growth. The company is exploring partnerships with major retail chains, including Sprouts Farmers Market, Whole Foods Market, Walgreens, and CVS Pharmacy. Preliminary discussions are also underway with hotel chains and professional sports teams.

The expansion aims to significantly increase market presence and brand recognition. CBDL projects a potential revenue increase of up to 150% in the first year, with the CBD industry expected to grow at a CAGR of 22.2% over the next five years. The company is also targeting regional and local retailers to ensure comprehensive market coverage and meet various consumer needs.

CBDL emphasizes its commitment to product quality and customer satisfaction. Investments in production capabilities and supply chain efficiency are being made to support the expansion and ensure timely delivery of products. CBDL believes this move will solidify its leadership in the CBD industry and boost revenue.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.42%
Tags
none
-
Rhea-AI Summary

CBD Life Sciences Inc. (OTC PINK:CBDL), operating through its subsidiary The CBD Vault Inc., has announced a significant rebranding from LBC Bioscience Inc. to better reflect its commitment to innovation in the CBD market.

The CBD Vault now offers over 60 premium products, including pain creams, roll-ons, Delta-8 & Delta-10 gummies and cartridges, and Kava and Kratom beverages. The company aims to enhance its marketing efforts by hiring specialists in CBD marketing and advertising.

Additionally, CBD Life Sciences is exploring opportunities to acquire a marijuana dispensary and additional retail locations to diversify its market presence. The company is focused on leveraging the growing CBD market to deliver shareholder value.

CEO Lisa Nelson thanked consumers and shareholders for their support and highlighted the company's strategic steps towards growth and success.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.5%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
158.62%
Tags
-
Rhea-AI Summary

CBD Life Sciences (OTC PINK:CBDL) has announced a strategic partnership with Sunset Wholesale West, Arizona's largest wholesaler, through its subsidiary, LBC Bioscience Inc.. This alliance positions LBC to distribute its Elev8 gummies in large quantities, enhancing visibility across over 14,000 retailers, including dispensaries and smoke shops. CEO Lisa Nelson highlighted the potential for significant revenue growth and market expansion. The company aims to provide high-quality, affordable CBD products in 2023, continuing to address various health issues associated with CBD consumption.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Summary

CBD Life Sciences (CBDL) is launching a same day home delivery service for its CBD products across the Phoenix-Scottsdale Metro Area. This initiative, announced through its subsidiary LBC Bioscience Inc., aims to enhance convenience for local customers, especially the elderly. Orders can be placed via phone or online at www.lbcbioscienceinc.com. The company is also expanding its product offerings with a 2023 Mass Distributor Wholesale Catalog. All products are THC-free and undergo rigorous third-party lab testing. CBDL aims to improve customer accessibility and quality of life with its premium products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-25%
Tags
none
Rhea-AI Summary

CBD Life Sciences (OTC PINK: CBDL) announced the launch of a new CBD Oil infused with high-quality terpenes via its subsidiary, LBC Bioscience Inc.. The oil, available in strengths of 500MG, 1500MG, and 3000MG, will be sold online in 14 flavors. This product claims to have rapid absorption and is four times more potent than standard hemp-derived tinctures. The company has established a new manufacturing facility and anticipates increased revenue as it expands its product line. CBD's benefits extend to various health conditions, enhancing its market appeal.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Cbd Life Science (CBDL)?

The current stock price of Cbd Life Science (CBDL) is $0.0003 as of June 12, 2026.

What is the market cap of Cbd Life Science (CBDL)?

The market cap of Cbd Life Science (CBDL) is approximately 1.2M.